ArticleJournal of translational medicine2024

Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses.

Riley M Larkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.